101 related articles for article (PubMed ID: 3532456)
1. Positive antiglobulin cytotoxicity crossmatch in renal allograft recipients treated with cyclosporine.
Gifford RR; Doran MM; Ruth JA; Coppage ML; Winsett OE; Fish JC
Transplantation; 1986 Oct; 42(4):439-41. PubMed ID: 3532456
[No Abstract] [Full Text] [Related]
2. [Cytotoxic antiglobulin test--a sensitive method for HLA typing].
Májský A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(4):655-63. PubMed ID: 6184290
[TBL] [Abstract][Full Text] [Related]
3. The antiglobulin crossmatch in the cyclosporine era.
Zachary AA
Transplantation; 1987 Aug; 44(2):333-4. PubMed ID: 3629687
[No Abstract] [Full Text] [Related]
4. A past positive crossmatch does not affect allograft survival for cyclosporine-immunosuppressed primary and secondary renal transplant recipients.
Quinn T; Louis P; Mallis M; Senitzer DS; Tellis V; Matas A
Transplant Proc; 1989 Feb; 21(1 Pt 1):704. PubMed ID: 2650232
[No Abstract] [Full Text] [Related]
5. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
6. T-cell flow-cytometry crossmatch and long-term renal graft survival.
Rebibou JM; Bittencourt MC; Saint-Hillier Y; Chabod J; Dupont I; Bittard H; Chalopin JM; Hervé P; Tiberghien P
Clin Transplant; 2004 Oct; 18(5):558-63. PubMed ID: 15344960
[TBL] [Abstract][Full Text] [Related]
7. [The HLA crossmatching test before thrombocyte transfusion. Comparison of 3 methods].
Májský A; Prazák J
Vnitr Lek; 1990 Sep; 36(9):873-8. PubMed ID: 2251774
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cytotoxicity against donor HLA markers by posttransplant sera from renal allograft recipients.
Gülay Z; Bora S; Kavukçu S; Mehr MA; Elverdi B; Gülay H
Transplant Proc; 1995 Oct; 27(5):2683-4. PubMed ID: 7482874
[No Abstract] [Full Text] [Related]
9. Crossmatch in renal transplantation using a sensitive antiglobulin microlymphocytotoxicity test.
Ayed K; Sassi F; Ben Abdallah T
Transplant Proc; 2001 Aug; 33(5):2848-9. PubMed ID: 11498184
[No Abstract] [Full Text] [Related]
10. Evaluation of the effects of cyclosporine and HLA-typed source leukocyte transfusions (apheresis by-products) on the immune systems of highly sensitized prospective renal allograft recipients.
Weir MR; Shen SY; Dagher FJ; Bentley FR; Lesko L; Sadler JH
Transplant Proc; 1987 Feb; 19(1 Pt 1):735-7. PubMed ID: 3547838
[No Abstract] [Full Text] [Related]
11. Does cyclosporine improve the results of HLA-identical renal transplantation?
Flechner SM; Kerman RH; Van Buren CT; Lorber MI; Barker CJ; Kahan BD
Transplant Proc; 1987 Feb; 19(1 Pt 2):1485-8. PubMed ID: 3547866
[No Abstract] [Full Text] [Related]
12. Sucessful renal allograft in the presence of York (Yka) and autologous B-cell antibodies.
Connors SM; Myrberg SJ; Dodds K; Carpenter CB; Garovoy MR
Transplant Proc; 1979 Dec; 11(4):1944-6. PubMed ID: 394438
[No Abstract] [Full Text] [Related]
13. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
[TBL] [Abstract][Full Text] [Related]
14. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
[TBL] [Abstract][Full Text] [Related]
15. Role of suppressor cells in cyclosporine-treated allograft recipients.
Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
Transplant Proc; 1987 Feb; 19(1 Pt 2):1580-3. PubMed ID: 2950632
[No Abstract] [Full Text] [Related]
16. Effects of cyclosporine immunosuppression in humans.
Kerman RH
Transplant Proc; 1988 Apr; 20(2 Suppl 2):143-52. PubMed ID: 3284064
[No Abstract] [Full Text] [Related]
17. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
18. Effect of HLA matching in 10,000 cyclosporine-treated cadaver kidney transplants.
Opelz G
Transplant Proc; 1987 Feb; 19(1 Pt 1):641-6. PubMed ID: 3547834
[No Abstract] [Full Text] [Related]
19. Desensitization--which renal allograft recipients are suitable?
Thick M
Transplant Proc; 1987 Feb; 19(1 Pt 1):738-9. PubMed ID: 3274858
[No Abstract] [Full Text] [Related]
20. Cyclosporine A, hyperimmunized patients, and renal retransplantation.
Hendriks GF; de Lange P; Persijn GG; van Rood JJ
Transplant Proc; 1987 Feb; 19(1 Pt 1):733-4. PubMed ID: 3274857
[No Abstract] [Full Text] [Related]
[Next] [New Search]
